Abstract:
Disclosed is a method for producing a 2-oxazoline analogue or a 1,3-oxazine analogue represented by the general formula (3) below wherein 1,2-aminoalcohol or 1,2-aminothiol is reacted with a,a-dihaloamine. (3) (In the formula, n is 0 or 1; R represents an oxygen atom or a sulfur atom; R 1 , R 2 and R 3 respectively represent an atom or group shown in the groups 1-3 below; and R 0 represents an atom or group shown in the group 2 or 3 below. In this connection, two or more of R 1 , R 2 and R 3 may combine together to form a ring. Group 1: a hydrogen atom, a halogen atom, a nitro group, a cyano group, a formyl group, a carboxyl group, a sulfonyl group, a sulfinoyl group or sulfenyl group Group 2: an alkyl group which may have an arbitrary substituent, an aryl group or an aralkyl group Group 3: an alkyl-substituted, aryl-substituted or aralkyl-substituted oxy group, a carbonyl group, an oxycarbonyl group, a carbonyloxy group, a thio group, a sulfonyl group, a sulfinoyl group or sulfenyl group)
Abstract translation:公开了由下列通式(3)表示的2-恶唑啉类似物或1,3-恶嗪类似物的制备方法,其中1,2-氨基醇或1,2-氨基硫醇与a-二卤代胺反应。 (3)(式中,n为0或1; R表示氧原子或硫原子; R 1,R 2,R 3, / SUP>分别表示下述1-3组中的原子或基团,R 0表示下述2或3组中的原子或基团,在这一点上,两个或多个 R 1,R 2和R 3可以结合在一起形成环。组1:氢原子,卤素原子,硝基 基团,氰基,甲酰基,羧基,磺酰基,亚磺酰基或亚磺酰基2:可以具有任意取代基的烷基,芳基或芳烷基组3:烷基 - 取代的芳基取代或芳烷基取代的氧基,羰基,氧羰基,羰氧基,硫基,磺酰基,亚磺酰基或亚磺酰基)
Abstract:
The invention relates to a method illustrated in model 1 for synthesising heterocyclic compounds of formula (I). According to said method, isothiocyanate of formula (II) is reacted with the primary amine of formula (III) to obtain thiourea of formula (IV). The thiourea of formula (IV) is then converted into the heterocycle of formula (I) using a base and a sulfonic acid.
Abstract:
Benzene derivatives of the general formula (1) exhibiting a fibrinolysis accelerating effect and being useful as the active ingredient of orally administrable antithrombotic or thrombolytic agents: (1)
Abstract:
The present invention relates to a novel receptor, in particular to a new type of receptor with an affinity for compounds of the oxazoline class, compounds which bind to this receptor, and the use of these compounds in the treatment of diseases, especially diseases of the central nervous system, the cardiovascular system and the kidney.
Abstract:
A compound represented by general formula (I) and a pest control agent, whrein Z represents oxygen or sulfur; Y represents halogen, optionally substituted alkyl, optionally substituted alkoxycarbonyl, optionally substituted alkoxy, S(O)pr (wherein p represents an integer of 0 to 2, and r represents optionally substituted alkyl), nitro, cyano, or optionally substituted amino; m represents an integer of 1 to 3; R1, R2 and R4 may be the same or different from one another and each represents hydrogen, optionally substituted alkyl or optionally substituted phenyl; R3 represents alkyl, alkenyl, aralkyl, cycloalkyl, phenyl, naphthyl, pyridyl, furyl or thienyl, each of which may be substitued by halogen, hydroxy, optionally substituted alkyl, or the like.
Abstract translation:由通式(I)表示的化合物和害虫防治剂,Z表示氧或硫; Y表示卤素,任选取代的烷基,任选取代的烷氧基羰基,任选取代的烷氧基,S(O)pr 1(其中p表示0至2的整数,r 1表示任选取代的烷基),硝基,氰基, 或任选取代的氨基; m表示1〜3的整数, R 1,R 2和R 4可以彼此相同或不同,并且各自表示氢,任选取代的烷基或任选取代的苯基; R 3表示烷基,烯基,芳烷基,环烷基,苯基,萘基,吡啶基,呋喃基或噻吩基,其各自可以被卤素,羟基,任选取代的烷基等取代。
Abstract:
Nitrogen-containing heterocyclic compounds of formula (II) wherein R1 and R2 which signifie an alkyl group with 1 to 15 C atoms, wherein also one or several CH2-groups can be replaced by a grouping selected on the group -O-, -S-, -CO-, -O-CO-, -O-COO-, -CO-O-, -CH=CH-, -CH-halogen and -CHCN- or also by a combination of two suited groups, whereby two heteroatoms are not directly linked with one another, m is 0 or 1, Ar is 1,4-phenylen, 4,4'-bi-phenyl or 2,6-naphthylen, in each of which one or several CH-groups are replaced by an N, Z signifies -CO-O-, -O-CO-, -CH2O-, -OCH2-, CH2CH2-, -CH2CHCN-, -CHCNCH2-, -CH=CH or a single bond and A is 1, 4-cyclohexylen, unsubstituted or substituted and the 1- or 4- position, with the condition that in the case where A=unsubstituted 1,4 cyclohexil Z is -CHCNCH2- or -CH2CHCN and/or an at least one of the residues R1 and R2 at least one CH2-group is replaced by -CHCN-, such compounds being suitable for use as components of smectic liquid crystal phases.
Abstract:
The present invention disclosed herein is a bile acid sequestering composition comprising the resin chelate with improved affinity/binding activity towards bile acid(s) and to the process for preparation thereof.
Abstract:
Disclosed are a 2-substituted imino-1,3-oxazine derivative having a cannabinoid receptor agonist effect, and a pharmaceutical composition containing such a compound as an active constituent. Specifically disclosed is a compound represented by the general formula (I) below, an optically active substance thereof, a pharmaceutically acceptable salt thereof, or a solvate of any one of them. (I) (In the formula, R 1 represents an optionally substituted aryl or the like; R 2 represents a C 1 -C 6 alkyl or the like, R 3 represents a C 1 -C 6 alkyl or the like, or alternatively R 2 and R 3 may form a 3-8 membered cycloalkane together with an adjacent carbon atom which may be substituted by a C 1 -C 4 alkyl; and R 4 represents a group represented by the following formula: -C(=X)-Y-R 5 (wherein R 5 represents an optionally substituted C 1 -C 4 alkyl or the like, X represents a sulfur atom or the like, and Y represents a sulfur atom or the like) or the like.)